General
Preferred name
OXIPEROMIDE
Synonyms
Peromide ()
Oxiperomida ()
NSC-313681 ()
R 4714 ()
R-4714 ()
P&D ID
PD062369
CAS
5322-53-2
Tags
available
drug candidate
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Peromide has putative antipsychotic and pro-cognitive potential. It was developed as a dopamine-receptor antagonist, with Ki=5.5 nM for dopamine 2 long receptor.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
ChEMBL Drugs
Drug Repurposing Hub
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Ki Database
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Molecular Weight
337.18
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
3.46
TPSA
50.52
Fraction CSP3
0.35
Chiral centers
0.0
Largest ring
6.0
QED
0.77
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
Dopamine Receptor antagonist
Source data
